Ligand: Q1 Earnings Snapshot

Published: 2026-05-07 07:29:06 ET LGND

Published on 05/07/2026 at 07:29 am EDT

JUPITER, Fla. (AP) — JUPITER, Fla. (AP) — Ligand Pharmaceuticals Inc. (LGND) on Thursday reported a loss of $13.3 million in its first quarter.

On a per-share basis, the Jupiter, Florida-based company said it had a loss of 67 cents. Earnings, adjusted for non-recurring costs and stock option expense, came to $1.63 per share.

The results fell short of Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for earnings of $1.85 per share.

The drugmaker posted revenue of $51.7 million in the period, which also missed Street forecasts. Three analysts surveyed by Zacks expected $59.9 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on LGND at https://www.zacks.com/ap/LGND

For copyright information, check with the distributor of this item, STATS Perform dba Automated Insights. , source Associated Press News